Amneal Pharmaceuticals $600 million notes offering
We advised Amneal Pharmaceuticals on its high-yield notes offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Tempus AI $750 million convertible senior notes offering
The 0.75% convertible senior notes are due 2030
Medtide HK$411.2 million IPO
We advised Medtide on its IPO and HKEX listing
Mirxes Holding Company HK$1.09 billion IPO
We advised Mirxes on its IPO and HKEX listing
ADC Therapeutics $100 million private placement
We advised ADC Therapeutics on the equity offering
Omada Health $172.6 million IPO
The shares are listed on the Nasdaq Global Select Market
PegBio IPO
We advised PegBio on its IPO and HKEX listing
Hinge Health $503 million IPO
The shares are listed on the New York Stock Exchange
Kenvue $750 million senior notes offering
The investment-grade notes are due 2032
Atara Biotherapeutics registered direct offering
The stock is listed on Nasdaq